# A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver

> **NCT05677113** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 115 (estimated)

## Conditions studied

- Colorectal Cancer
- Liver Metastases

## Interventions

- **DRUG:** QBECO
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05677113
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2027-02
- **Final completion:** 2031-02-01
- **Target enrollment:** 115 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05677113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05677113, "A Study of QBECO Versus Placebo in the Treatment of Colorectal Cancer That Has Spread to the Liver". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05677113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*